Our mission is to be the definitive full service contract manufacturer for the production of clinical scale therapeutic proteins and antibodies for the biotech industry. The Cytovance team understands from first-hand experience the need for more options for comprehensive contract manufacturing services. While there is some debate about the size of the cell culture capacity shortage for commercial stage biopharmaceutical products, the adequacy of clinical capacity is an equally critical question, especially for development stage companies. The clinical manufacturing capacity that does exist is mostly controlled by larger therapeutics companies or commercial scale contractors that are often inaccessible to development stage clients.